Evidence map›Paper›PMID 32343877›Full record

ArticlePediatric blood & cancer2020

Diverse populations and enrollment in pediatric cancer clinical trials: Challenges and opportunities.

Paula Aristizabal

Abstract read
In one paragraph

Article in Pediatric blood & cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The most vulnerable pediatric cancer patients.Lancet regional health. Americas · 2023
    Article
  9. Population-Based Impact of Rurality and Neighborhood-Level Socioeconomic Disadvantage on Pediatric Cancer Mortality in Washington State.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  10. Article
  11. Disparities in Pediatric Oncology: The 21st Century Opportunity to Improve Outcomes for Children and Adolescents With Cancer.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2021
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Paula AristizabalDivision of Pediatric Hematology/Oncology, Department of Pediatrics, Rady Children's Hospital San Diego, University of California San Diego/Peckham Center for Cancer and Blood Disorders, San Diego, California.ORCID 0000-0003-0588-1532

Funding

COMPRENDO: Adaptation and Implementation of a Peer-Navigation Intervention to Improve Research Literacy and Diversity in Pediatric Leukemia Clinical TrialsK08CA230306 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ARISTIZABAL, PAULA · 2018 to 2023
$1.4M
NCI NIH HHS K08 CA230306
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Patient SelectionChildClinical Trials as TopicEthnicityHumansMinority GroupsNeoplasmsPatient Participation

Identifiers

PMID32343877
PMCPMC8203427

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.